Improved Outcomes in the Management of Hepatic Encephalopathy

What can we help you find?
Insights on the use of liver transplantation as a treatment for severe hepatic encephalopathy.
Experts discuss management of challenging patients with repeat recurrence of hepatic encephalopathy despite being on maximal medical therapy.
Recommendations for providers on protocolizing the care of patients with hepatic encephalopathy to prevent recurrence and rehospitalization.
An analysis of the data from clinical trials looking at the safety and efficacy of rifaximin (Xifaxan) in combination with lactulose for the treatment of recurrent overt hepatic encephalopathy.
Panelists elaborate on the standard approaches for the treatment of hepatic encephalopathy and discuss the 2 agents most commonly used: lactulose and rifaximin (Xifaxan).
A discussion on the guidelines that apply to the management and treatment of patients with hepatic encephalopathy.
Challenges associated with the diagnosis and classification of minimal hepatic encephalopathy.
An overview of the West Haven criteria for the classification of overt and covert hepatic encephalopathy (HE).
Experts review the wide spectrum of neuropsychiatric manifestations that patients with hepatic encephalopathy may present with.
The epidemiology, prevalence, and classification of hepatic encephalopathy.
Experts emphasize the importance of utilizing diagnostic paracentesis to identify underlying infections or other precipitants of hepatic encephalopathy.
An explanation of the development of hepatic encephalopathy in patients with acute liver failure versus patients with cirrhosis.
+ Load More